These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 30907322)

  • 1. Does Intraneuronal Accumulation of Carboxyl-terminal Fragments of the Amyloid Precursor Protein Trigger Early Neurotoxicity in Alzheimer's Disease?
    Lauritzen I; Pardossi-Piquard R; Bourgeois A; Bécot A; Checler F
    Curr Alzheimer Res; 2019; 16(5):453-457. PubMed ID: 30907322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accumulation of amyloid precursor protein C-terminal fragments triggers mitochondrial structure, function, and mitophagy defects in Alzheimer's disease models and human brains.
    Vaillant-Beuchot L; Mary A; Pardossi-Piquard R; Bourgeois A; Lauritzen I; Eysert F; Kinoshita PF; Cazareth J; Badot C; Fragaki K; Bussiere R; Martin C; Mary R; Bauer C; Pagnotta S; Paquis-Flucklinger V; Buée-Scherrer V; Buée L; Lacas-Gervais S; Checler F; Chami M
    Acta Neuropathol; 2021 Jan; 141(1):39-65. PubMed ID: 33079262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Transcription Factor EB Reduces the Intraneuronal Accumulation of the Beta-Secretase-Derived APP Fragment C99 in Cellular and Mouse Alzheimer’s Disease Models.
    Bécot A; Pardossi-Piquard R; Bourgeois A; Duplan E; Xiao Q; Diwan A; Lee JM; Lauritzen I; Checler F
    Cells; 2020 May; 9(5):. PubMed ID: 32408680
    [No Abstract]   [Full Text] [Related]  

  • 4. Intraneuronal aggregation of the β-CTF fragment of APP (C99) induces Aβ-independent lysosomal-autophagic pathology.
    Lauritzen I; Pardossi-Piquard R; Bourgeois A; Pagnotta S; Biferi MG; Barkats M; Lacor P; Klein W; Bauer C; Checler F
    Acta Neuropathol; 2016 Aug; 132(2):257-276. PubMed ID: 27138984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inefficient quality control of ribosome stalling during APP synthesis generates CAT-tailed species that precipitate hallmarks of Alzheimer's disease.
    Rimal S; Li Y; Vartak R; Geng J; Tantray I; Li S; Huh S; Vogel H; Glabe C; Grinberg LT; Spina S; Seeley WW; Guo S; Lu B
    Acta Neuropathol Commun; 2021 Oct; 9(1):169. PubMed ID: 34663454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MT5-MMP controls APP and β-CTF/C99 metabolism through proteolytic-dependent and -independent mechanisms relevant for Alzheimer's disease.
    García-González L; Paumier JM; Louis L; Pilat D; Bernard A; Stephan D; Jullien N; Checler F; Nivet E; Khrestchatisky M; Baranger K; Rivera S
    FASEB J; 2021 Jul; 35(7):e21727. PubMed ID: 34117802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lysosomal Dysfunction in Down Syndrome Is APP-Dependent and Mediated by APP-βCTF (C99).
    Jiang Y; Sato Y; Im E; Berg M; Bordi M; Darji S; Kumar A; Mohan PS; Bandyopadhyay U; Diaz A; Cuervo AM; Nixon RA
    J Neurosci; 2019 Jul; 39(27):5255-5268. PubMed ID: 31043483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Pursuit of the "Inside" of the Amyloid Hypothesis-Is C99 a Promising Therapeutic Target for Alzheimer's Disease?
    Takasugi N; Komai M; Kaneshiro N; Ikeda A; Kamikubo Y; Uehara T
    Cells; 2023 Jan; 12(3):. PubMed ID: 36766796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advanced Assay Monitoring APP-Carboxyl-Terminal Fragments as Markers of APP Processing in Alzheimer Disease Mouse Models.
    García-Osta A; Cuadrado-Tejedor M
    Methods Mol Biol; 2016; 1303():117-23. PubMed ID: 26235062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ErbB2 regulates autophagic flux to modulate the proteostasis of APP-CTFs in Alzheimer's disease.
    Wang BJ; Her GM; Hu MK; Chen YW; Tung YT; Wu PY; Hsu WM; Lee H; Jin LW; Hwang SL; Chen RP; Huang CJ; Liao YF
    Proc Natl Acad Sci U S A; 2017 Apr; 114(15):E3129-E3138. PubMed ID: 28351972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intraneuronal accumulation of C99 contributes to synaptic alterations, apathy-like behavior, and spatial learning deficits in 3×TgAD and 2×TgAD mice.
    Bourgeois A; Lauritzen I; Lorivel T; Bauer C; Checler F; Pardossi-Piquard R
    Neurobiol Aging; 2018 Nov; 71():21-31. PubMed ID: 30071370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amino-terminal modification and tyrosine phosphorylation of [corrected] carboxy-terminal fragments of the amyloid precursor protein in Alzheimer's disease and Down's syndrome brain.
    Russo C; Salis S; Dolcini V; Venezia V; Song XH; Teller JK; Schettini G
    Neurobiol Dis; 2001 Feb; 8(1):173-80. PubMed ID: 11162251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C99 selectively accumulates in vulnerable neurons in Alzheimer's disease.
    Pulina MV; Hopkins M; Haroutunian V; Greengard P; Bustos V
    Alzheimers Dement; 2020 Feb; 16(2):273-282. PubMed ID: 31677937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting γ-secretase triggers the selective enrichment of oligomeric APP-CTFs in brain extracellular vesicles from Alzheimer cell and mouse models.
    Lauritzen I; Bécot A; Bourgeois A; Pardossi-Piquard R; Biferi MG; Barkats M; Checler F
    Transl Neurodegener; 2019; 8():35. PubMed ID: 31827783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BACE1 Cleavage Site Selection Critical for Amyloidogenesis and Alzheimer's Pathogenesis.
    Zhang S; Wang Z; Cai F; Zhang M; Wu Y; Zhang J; Song W
    J Neurosci; 2017 Jul; 37(29):6915-6925. PubMed ID: 28626014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autophagosomes cooperate in the degradation of intracellular C-terminal fragments of the amyloid precursor protein
    González AE; Muñoz VC; Cavieres VA; Bustamante HA; Cornejo VH; Januário YC; González I; Hetz C; daSilva LL; Rojas-Fernández A; Hay RT; Mardones GA; Burgos PV
    FASEB J; 2017 Jun; 31(6):2446-2459. PubMed ID: 28254759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TMEM30A is a candidate interacting partner for the β-carboxyl-terminal fragment of amyloid-β precursor protein in endosomes.
    Takasugi N; Araya R; Kamikubo Y; Kaneshiro N; Imaoka R; Jin H; Kashiyama T; Hashimoto Y; Kurosawa M; Uehara T; Nukina N; Sakurai T
    PLoS One; 2018; 13(8):e0200988. PubMed ID: 30086173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The transmembrane amyloid precursor C99 protein exhibits non-specific interaction with tau.
    Britton RJ; Hutchison JM; Sanders CR
    Biochem Biophys Res Commun; 2021 Oct; 576():48-52. PubMed ID: 34481234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measuring APP carboxy-terminal fragments.
    Esposito LA
    Methods Mol Biol; 2011; 670():71-84. PubMed ID: 20967584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.